Please find enclosed an invitation to the annual general meeting at Photocure ASA on 30 April 2015 at 17:00 hours (CET). The meeting will take place at Photocure's head office at Hoffsveien 4, 2nd floor, 0275 Oslo, Norway.
The invitation including the meeting agenda, attachments, attendance slip and proxy form will also be sent to the company's shareholders with known address and is available at Photocure's corporate website www.photocure.com and at Oslo Stock Exchange's website.
On 7 April 2015, the Board of Directors of Photocure ASA approved the financial statements for the financial year 2014. The Company reported its preliminary and unaudited results for fourth quarter and full year 2014 on 12 February 2015. Compared to the preliminary figures a part of the loss on the PCI Biotech shares have been reclassified in the consolidated income statement from “Other Comprehensive Income” to “Impairment loss shares in PCI Biotech Holding”. The reclassified amount is NOK 8.2m. This has no impact on year-end consolidated balance sheet.
The Annual Report for Photocure ASA for the financial year 2014 will be published and made available on the company's website www.photocure.com 9 April 2015.
For further information, please contact:
CFO Erik Dahl
Tel: +47 450 55 000, Email: email@example.com
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.